tiprankstipranks
Advertisement
Advertisement

CHGCF Stock Latest News

Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
Company AnnouncementsChugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
3d ago
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
PremiumCompany Announcements
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
9d ago
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
PremiumCompany Announcements
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
12d ago
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
PremiumCompany Announcements
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
22d ago
CHGCF
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
PremiumCompany Announcements
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
24d ago
CHGCF
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
PremiumCompany AnnouncementsChugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
24d ago
CHGCF
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
Premium
Company Announcements
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
2M ago
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
Premium
Company Announcements
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
2M ago
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
PremiumCompany Announcements
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
2M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CHGCF Earnings this Week: How Will it Perform?
2M ago
Chugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
PremiumCompany Announcements
Chugai’s DONQ52 Celiac Study Advances, Adding a New Mid‑Stage Catalyst for CHGCF
3M ago
CHGCF
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
PremiumCompany Announcements
Chugai Pharmaceutical Completes Absorption-Type Merger of Renalys Pharma
3M ago
Chugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
PremiumCompany AnnouncementsChugai Highlights Positive Phase 3 Results and FDA Filing for Lilly’s Oral GLP-1 Orforglipron
4M ago
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
Premium
Company Announcements
Chugai Pharmaceutical to Merge with Renalys Pharma to Boost Kidney Disease Drug Development
5M ago
Chugai Pharmaceutical’s Promising Phase III Study on Ulcerative Colitis Treatment
Premium
Company Announcements
Chugai Pharmaceutical’s Promising Phase III Study on Ulcerative Colitis Treatment
5M ago
CHGCF
Chugai Pharmaceutical Advances Satralizumab Trial for Autoimmune Encephalitis
PremiumCompany Announcements
Chugai Pharmaceutical Advances Satralizumab Trial for Autoimmune Encephalitis
5M ago
CHGCF
Chugai Pharmaceutical’s Satralizumab Study: A Potential Game-Changer for MOGAD Treatment?
PremiumCompany Announcements
Chugai Pharmaceutical’s Satralizumab Study: A Potential Game-Changer for MOGAD Treatment?
5M ago
CHGCF
Chugai’s Phase III Study on Divarasib: A Potential Game-Changer in Lung Cancer Treatment
PremiumCompany Announcements
Chugai’s Phase III Study on Divarasib: A Potential Game-Changer in Lung Cancer Treatment
5M ago
CHGCF
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
PremiumCompany Announcements
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
5M ago
CHGCF
Chugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
PremiumCompany AnnouncementsChugai Pharmaceutical’s Promising Phase III Study on Crohn’s Disease Treatment
5M ago
CHGCF
Chugai’s Promising Lung Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
Chugai’s Promising Lung Cancer Study: A Potential Game-Changer?
5M ago
CHGCF
Chugai Pharmaceutical’s AUBE00 Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Chugai Pharmaceutical’s AUBE00 Study: A Potential Game-Changer in Cancer Treatment
5M ago
CHGCF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >